Octapharma Demonstrates Commitment to Improving Haemophilia and Allied Disorders
Octapharma demonstrates commitment to improving haemophilia, a treatment at the 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)...
Feb 08